Both Melanoma and Renal Cell Carcenoma are also orphan drug...

Both Melanoma and Renal Cell Carcenoma are also orphan drug candidates. They have to go for their best prospects. Resources are limited. As they stated in the announcement "mesothelioma, non small cell lung cancer and colorectal cancer are strong alternative activity trial targets; and each may be the subject of supplementary activity trials at a later date"
With so many possible targets they have to start somewhere. I think it is a shame they havnt had more govt support for a mesothelioma trial.